|
|||||
|
|
KRAS mutational testing in the selection of patients for EGFR-targeted therapies |
|
| Authors: | Joaquin Garcia Gregory J. Riely Khedoudja Nafa Marc Ladanyi |
| Affiliation: | 1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York;2. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York;3. Human Oncology & Pathogenesis Program, Memorial Sloan–Kettering Cancer Center, New York, New York |
| Abstract: | |
| Keywords: | Lung cancer Colon cancer Kinase Erlotinib Gefinitib Cetuximab Panitimumab |
| 本文献已被 ScienceDirect 等数据库收录！ | |